Psilocybin

This article was originally published on Psychedelic Spotlight and appears here with permission. In an unanimous move, Berkeley has officially deprioritized arrests for possession and use of psilocybin and ayahuasca. Berkeley has long been an epicenter of psychedelic research and culture in the...

With timelines for the submission of approval for MDMA-assisted therapy becoming more clear, COMPASS Pathways (NASDAQ: CMPS) has provided their own estimation on when psilocybin-assisted therapy may obtain regulatory approval. Today, the company prognosticated on when that may be,...

The quest to advance psychedelic medicine in Canada received a big boost today. The Minister of Mental Health and Addictions, Carolyn Bennett, announced an investment of nearly $3 million through the Canadian Institutes of Health Research. This funding will support three clinical...

This article was originally published on Cannabis.net and appears here with permission. Psilocybin magic mushrooms has been proven to help treat many treatment-resistant conditions. These include depression, post-traumatic stress disorder, anxiety, and OCD to name a few. But did you know that...

This article was originally published on Microdose and appears here with permission Feeling empowered by the growing public support and diminishing social stigma, a steady stream of celebrities are opening up about mental health and the positive effects of psychedelics on their lives. And...

This article was originally published on Psychedelic Spotlight and appears here with permission.  A new study sheds light on whether psychedelics can safely be used by older adults, revealing previously unknown safety profiles and efficacy of psychedelics for older people, and challenging...

Natural psychedelics drug developer Filament Health Corp. (OTCQB: FLHLF) shared its interim financial results and further business highlights for the first quarter ended March 31, 2023. These results were assembled by the company’s management and were not reviewed by the independent...

This article was originally published on Leafly and appears here with permission.  A mushroom trip can be life-changing, but can the experience of a cosmic, transformative journey also spark a desire to do it again, and again, and again? Psilocybin, the main active compound in mushrooms, is...

Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTCPK: XTXXF) reported on Wednesday that Adastra Labs got the green light from Health Canada earlier this month for its amendment to include cocaine as a substance that the company can legally possess, produce, sell and distribute. The Langley,...

Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022. The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15 million as of Feb. 14, 2023. The quarter’s net loss was $8 million compared to $12.9 million...

This article was originally published on Psychedelic Spotlight and appears here with permission. DMT and psilocybin are both powerful elements of Mother Nature's alchemy, but do they offer an identical journey? Let’s explore to find out. Have you ever found yourself wondering about the...

This article was originally published on PSYCH and appears here with permission. UK-based COMPASS Pathways (NASDAQ: CMPS) recently published data from its Phase IIb trials, with COMP360 psilocybin therapy for treatment-resistant depression. This follows the release of the design for the...

With the medical potential of both psilocybin and CBD, there is an increasing interest in exploring the possibilities of combining them for therapeutic benefit. Psilocybin and CBD are two compounds found in nature that have been gaining attention for their potential therapeutic benefits. ...

From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions. Huge news tonight coming out of Australia. The...

Drug discovery company Mindset Pharma (OTCQB: MSSTF) has been greenlighted by the US Patent and Trademark Office (USPTO) on its application “Psilocin Derivatives As Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.”  The application includes the company’s...